1 Product identity
Adreno-Lyph-Plus
Other Combinations Tablet or Pill 14 ingredients DSLD #27514Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-11-25
2 Ingredients (14)
IngredientGroupSafety
Vitamin B1Thiamin—
Vitamin B6Vitamin B6—
Bioflavonoid ComplexBlend (Combination)—
235 mg tissue concentrateBovine (unspecified)—
AdrenalAdrenals—
PituitaryPituitary—
ParotidParotid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Pantothenic Acid — Generally Safe
⚠ Diarrhea at very high doses
Riboflavin — Generally Safe
⚠ Harmless yellow urine
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Magnesium — Generally Safe
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
L-Methionine — Conditionally Safe
⚠ Raises homocysteine levels
⚠ May promote tumor growth
Choline — Generally Safe
⚠ Fishy odor at high doses
4 Label claims
• All Other
5 Data source
DSLD ID27514
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-11-25
6 More from Nutri-West
View Nutri-West Safety Scorecard → 186 products
#1 - AD#2 - CFAdreno - Lyph - SymAdreno-Lyph 80Adreno-Lyph-160Adreno-Lyph-Para7 Cite this page
Vancouver
Pkhakadze G. Adreno-Lyph-Plus — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/products/adreno-lyph-plus-27514/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG